Reimagining Pharmaceutical Market Exclusivities: Should the Duration of Guaranteed Monopoly Periods Be Value Based?
作者:
主题词
费用效益分析(Cost-Benefit Analysis);药品和麻醉品检定(Drug and Narcotic Control);药物, 通用名(Drugs, Generic);卫生保健改革(Health Care Reform);人类(Humans);专利(主题)(Patents as Topic);处方药(Prescription Drugs);公共卫生(Public Health);技术评估, 生物医学(Technology Assessment, Biomedical)
DOI
10.1016/j.jval.2021.04.1277
PMID
34452713
发布时间
2021-12-30
- 浏览0

Value in health
1328-1334页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文